NMAX Form 4: David Gandler receives 11,738 stock options
Rhea-AI Filing Summary
Newsmax, Inc. (NMAX) director David Gandler was granted a stock option under the issuer's 2025 Omnibus Equity Incentive Plan. The option covers 11,738 common shares with an exercise price of $14.91 per share, was granted on 08/25/2025, and expires on 08/25/2035. The option becomes exercisable on the 12-month anniversary of the grant provided the reporting person remains in service through that date.
The Form 4 was filed as a one-person filing and signed by an attorney-in-fact on 08/26/2025. The filing discloses the derivative award and the mechanics governing vesting and exercisability but contains no other compensatory terms or additional transactions.
Positive
- Option grant disclosed for director David Gandler, providing clear alignment of director incentives with long‑term shareholder value.
- Time‑based vesting (12‑month cliff) supports retention and links exercisability to continued service.
Negative
- None.
Insights
TL;DR: Routine director option grant aligning executive incentives through time‑based vesting; no immediate dilution or sales disclosed.
The reported option award of 11,738 shares at a $14.91 exercise price is a standard equity compensation tool for a director. Vesting is time‑based, becoming exercisable on the 12‑month anniversary if service continues, which supports retention. The Form 4 cleanly discloses grant mechanics and expiration, but it does not disclose share-count context versus outstanding shares or any acceleration/change‑of‑control provisions, limiting assessment of shareholder dilution risk.
TL;DR: Disclosure is clear and routine; the award is a derivative grant with fixed exercise price and ten‑year term.
The derivative security is an option exercisable into 11,738 common shares, with a ten‑year term (08/25/2025–08/25/2035) and a stated exercise price of $14.91. The Form 4 indicates no immediate change in beneficial ownership of common stock and shows the instrument is currently recorded as held directly. The filing provides essential terms but omits aggregate post‑grant ownership percentage and any tax or settlement provisions, which constrains full investor impact analysis.